MITO 46
Evaluation of different treatment sequences and drug-drug interactions (DDIs) in Ovarian Cancer patients treated with PARP inhibitors: Retrospective/prospective observational study
STATO: Richiesta adesione centri in corso
PATOLOGIA: Ovaio
CENTRO COORDINATORE MITO: Policlinico Umberto I Università "La Sapienza" - Roma
PRINCIPAL INVESTIGATOR: Giacomo Barchiesi
CO INVESTIGATOR:
STUDY COORDINATOR: